The Analytical Core Shared Service provides state of the art instrumentation for mass spectrometry-based chemical and biochemical analyses and personnel to assist investigators in the design and application of analytical methods and the interpretation of data. The Analytical Core is supported both by the Arizona Cancer Center (ACC) and the Southwest Environmental Health Sciences Center (SWEHSC) core grants. The objectives of the Analytical Core are to aid ACC and SWEHSC investigators: . In the identification of unknown compounds, . In the development of mass spectrometry based analytical methods, and . In the design of experiments and interpretation of analytical data. The Analytical Core is directed by Daniel C. Liebler, Ph.D., Associate Professor of Pharmacology and Toxicology and staffed by Thomas D. McClure, Ph.D., facility manager and one research specialist each supported by the ACC and SWEHSC core grants. Instrumentation in the Analytical Core includes a Finnigan TSQ7000 triple quadrupole instrument with electrospray and atmospheric pressure chemical ionization for HPLC-MS and HPLC-MS-MS work. This instrument is capable of protein and peptide sequence analysis as well as the analysis of a wide variety of biomolecules and macromolecules. The Analytical Core also houses a Finnigan MD-800 bench- top GC-MS system and a Hewlett Packard 1050 diode array HPLC system for method development. All analytical work is done by appointment. There is no charge assessed to ACC and SWEHC investigators for method development, whereas a flat per-sample fee is charge to recover costs of instrument service contracts.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA023074-22S2
Application #
6217332
Study Section
Project Start
1999-07-01
Project End
2000-06-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
22
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Arizona
Department
Type
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Knudsen, Erik S; Balaji, Uthra; Mannakee, Brian et al. (2018) Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility. Gut 67:508-520
Boese, Cody J; Nye, Jonathan; Buster, Daniel W et al. (2018) Asterless is a Polo-like kinase 4 substrate that both activates and inhibits kinase activity depending on its phosphorylation state. Mol Biol Cell 29:2874-2886
Sohail, Atif; Mushtaq, Adeela; Iftikhar, Ahmad et al. (2018) Emerging immune targets for the treatment of multiple myeloma. Immunotherapy 10:265-282
Doane, Cynthia J; Patil, Karuna; Hoffman, Emely A et al. (2018) Supernumerary Incisors in CB6F1 Mice Conditioned with Chemotherapy and Total Body Irradiation before Bone Marrow Transplantation. Comp Med 68:349-352
Bea, J W; Hsu, C-H; Blew, R M et al. (2018) Use of iDXA spine scans to evaluate total and visceral abdominal fat. Am J Hum Biol 30:
Lent, Adrienne B; O'Connor, Patrick A; Reikowsky, Ryan C et al. (2018) Quit outcomes among clients ineligible for cessation medication through the state quitline: a retrospective, observational study. BMC Public Health 18:1001
Bulkley, Joanna E; McMullen, Carmit K; Grant, Marcia et al. (2018) Ongoing ostomy self-care challenges of long-term rectal cancer survivors. Support Care Cancer 26:3933-3939
Zaim, Samir Rachid; Li, Qike; Schissler, A Grant et al. (2018) Emergence of pathway-level composite biomarkers from converging gene set signals of heterogeneous transcriptomic responses. Pac Symp Biocomput 23:484-495
Kobes, Joseph E; Georgiev, George I; Louis, Anthony V et al. (2018) A Comparison of Iron Oxide Particles and Silica Particles for Tracking Organ Recellularization. Mol Imaging 17:1536012118787322
Kelly, K R; Espitia, C M; Zhao, W et al. (2018) Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy. Leukemia 32:230-233

Showing the most recent 10 out of 1336 publications